StockData

BioScience Health Innovations, Inc. (BHIC) stock

BHICOTCServices-Computer Processing & Data PreparationFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$6.78+0.00 (0.00%)

Close on Oct 16, 2026Market cap $79.22MP/E –Yield –

BioScience Health Innovations gross margin

Gross margin is gross profit as a percentage of revenue.

BioScience Health Innovations's gross margin for the twelve months ending Jun 30, 2026 was 53.8%. For fiscal 2025 it was 57.0%, against 70.9% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202557.0%−14.0
FY2024Dec 31, 202470.9%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q2 FY2026CQ2 2026Jun 30, 202663.6%+2.5
Q1 FY2026CQ1 2026Mar 31, 202664.7%−8.4
Q4 FY2025CQ4 2025Dec 31, 202536.4%−19.2
Q3 FY2025CQ3 2025Sep 30, 202561.7%−12.4
Q2 FY2025CQ2 2025Jun 30, 202561.1%−19.7
Q1 FY2025CQ1 2025Mar 31, 202573.0%−11.5
Q4 FY2024CQ4 2024Dec 31, 202455.6%–
Q3 FY2024CQ3 2024Sep 30, 202474.1%–
Q2 FY2024CQ2 2024Jun 30, 202480.8%–
Q1 FY2024CQ1 2024Mar 31, 202484.6%–

More BioScience Health Innovations figures

See a number that looks wrong?